{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:39:04Z","timestamp":1793403544489,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":895,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jmoldx.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T10:31:57Z","timestamp":1494498717000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase\/AKT\/Mammalian Target of Rapamycin Pathway"],"prefix":"10.1016","volume":"19","author":[{"given":"Gozde","family":"Akgumus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2017.04.001_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(87)80249-9","article-title":"Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin","volume":"16","author":"Happle","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A mosaic activating mutation in AKT1 associated with the Proteus syndrome","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","article-title":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome","volume":"90","author":"Kurek","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0092-8674(91)90411-Q","article-title":"Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T\/pp60 c-src complexes, and PI3-kinase","volume":"65","author":"Otsu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.c.31361","article-title":"Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP","volume":"163","author":"Mirzaa","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib7","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1371\/journal.pbio.0050095","article-title":"Intramolecular and intermolecular interactions of protein kinase B define its activation in\u00a0vivo","volume":"5","author":"Calleja","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib9","doi-asserted-by":"crossref","first-page":"21920","DOI":"10.1074\/jbc.271.36.21920","article-title":"Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation","volume":"271","author":"Kohn","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib10","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/MCB.25.5.1869-1878.2005","article-title":"Role for Akt3\/protein kinase B\u03b3 in attainment of normal brain size","volume":"25","author":"Easton","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib11","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1242\/dev.01864","article-title":"Essential role of protein kinase B\u03b3 (PKB\u03b3\/Akt3) in postnatal brain development but not in glucose homeostasis","volume":"132","author":"Tschopp","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/hmg\/ddq544","article-title":"A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice","volume":"20","author":"Tokuda","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.03.010","article-title":"Somatic activation of AKT3 causes hemispheric developmental brain malformations","volume":"74","author":"Poduri","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib14","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/ajmg.a.36101","article-title":"The AKT genes and their roles in various disorders","volume":"161","author":"Cohen","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib15","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ajmg.c.31362","article-title":"Molecular mechanisms of childhood overgrowth","volume":"163C","author":"Tatton-Brown","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4049\/jimmunol.171.4.1623","article-title":"FOXO transcription factors as regulators of immune homeostasis: molecules to die for?","volume":"171","author":"Birkenkamp","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib20","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1073\/pnas.0701005104","article-title":"Rare cancer-specific mutations in PIK3CA show gain of function","volume":"104","author":"Gymnopoulos","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib21","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1158\/0008-5472.CAN-04-4114","article-title":"Functional analysis of PIK3CA gene mutations in human colorectal cancer","volume":"65","author":"Ikenoue","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib22","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-08-0755","article-title":"PIK3CA cooperates with other phosphatidylinositol 3\u2032-kinase pathway mutations to effect oncogenic transformation","volume":"68","author":"Oda","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib24","first-page":"291","article-title":"A newly recognized hamartomatous syndrome","volume":"15","author":"Cohen","year":"1979","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00661895","article-title":"The proteus syndrome: partial gigantism of the hands and\/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections","volume":"140","author":"Wiedemann","year":"1983","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib26","first-page":"260","article-title":"Understanding Proteus syndrome, unmasking the elephant man, and stemming elephant fever","volume":"1","author":"Cohen","year":"1987","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO;2-O","article-title":"Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation","volume":"84","author":"Biesecker","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.ejhg.5201638","article-title":"The challenges of Proteus syndrome: diagnosis and management","volume":"14","author":"Biesecker","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/cge.12266","article-title":"Proteus syndrome review: molecular, clinical, and pathologic features","volume":"85","author":"Cohen","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajmg.c.30063","article-title":"Proteus syndrome: an update","volume":"137","author":"Cohen","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajmg.1320570117","article-title":"Neoplasms in Proteus syndrome","volume":"57","author":"Gordon","year":"1995","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ajmg.a.33926","article-title":"Pulmonary manifestations in Proteus syndrome: pulmonary varicosities and bullous lung disease","volume":"155","author":"Lim","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/1096-8628(20000731)93:3<234::AID-AJMG15>3.0.CO;2-9","article-title":"Multiple meningiomas, craniofacial hyperostosis and retinal abnormalities in Proteus syndrome","volume":"93","author":"Gilbert-Barness","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(01)07110-0","article-title":"PTEN mutations and proteus syndrome","volume":"358","author":"Eng","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(01)05412-5","article-title":"Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes","volume":"358","author":"Zhou","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib36","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.285.17.2240","article-title":"The multifaceted challenges of Proteus syndrome","volume":"285","author":"Biesecker","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jmg.38.7.480","article-title":"PTEN mutations are uncommon in Proteus syndrome","volume":"38","author":"Barker","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib38","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1002\/ajmg.a.32023","article-title":"Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients","volume":"143","author":"Sapp","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCD.0b013e328317a716","article-title":"Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome","volume":"18","author":"Alomari","year":"2009","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib40","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s00247-010-1559-0","article-title":"Perinatal clinical and imaging features of CLOVES syndrome","volume":"40","author":"Fernandez-Pineda","year":"2010","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib41","first-page":"265","article-title":"Cloves syndrome: a case report and perinatal diagnostic findings","volume":"25","author":"Puvabanditsin","year":"2014","journal-title":"Genet Couns"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib42","first-page":"845074","article-title":"A neonate with CLOVES syndrome","volume":"2014","author":"Sarici","year":"2014","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib43","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/ajmg.a.36672","article-title":"Prenatal diagnosis of CLOVES syndrome confirmed by detection of a mosaic PIK3CA variant in cultured amniocytes","volume":"164","author":"Emrick","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib44","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.onc.1208304","article-title":"PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas","volume":"24","author":"Lee","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2004-830497","article-title":"Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures","volume":"35","author":"Mirzaa","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib46","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/ajmg.a.32732","article-title":"Significant overlap and possible identity of macrocephaly capillary malformation and megalencephaly polymicrogyria-polydactyly hydrocephalus syndromes","volume":"149","author":"Gripp","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.a.34402","article-title":"Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis","volume":"158A","author":"Mirzaa","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pediatrneurol.2010.12.009","article-title":"MPPH syndrome: two new cases","volume":"44","author":"Osterling","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jmoldx.2017.04.006","article-title":"Molecular diagnosis of mosaic overgrowth syndromes using a custom designed next generation sequencing panel","volume":"19","author":"Chang","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib50","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng.2331","article-title":"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes","volume":"44","author":"Rivi\u00e8re","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1158\/2159-8290.CD-11-0116","article-title":"New routes to old places: PIK3R1 and PIK3R2 join PIK3CA and PTEN as endometrial cancer genes","volume":"1","author":"Herrero-Gonzalez","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib53","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ng.2329","article-title":"De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly","volume":"44","author":"Lee","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/hmg\/dds440","article-title":"Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly","volume":"22","author":"Rios","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib55","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.2948","article-title":"De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome","volume":"46","author":"Mirzaa","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00019605-199710000-00001","article-title":"Macrocephaly with cutis marmorata, haemangioma and syndactyly: a distinctive overgrowth syndrome","volume":"6","author":"Clayton-Smith","year":"1997","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1096-8628(19970502)70:1<67::AID-AJMG13>3.0.CO;2-V","article-title":"Macrocephaly-Cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities","volume":"70","author":"Moore","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib58","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/ajmg.a.32040","article-title":"Neuroimaging findings in macrocephaly\u2013capillary malformation: a longitudinal study of 17 patients","volume":"143","author":"Conway","year":"2007","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajmg.a.30235","article-title":"Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review","volume":"130A","author":"Lapunzina","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archdermatol.2008.545","article-title":"The misnomer \u201cmacrocephaly\u2013cutis marmorata telangiectatica congenita syndrome\u201d: report of 12 new cases and support for revising the name to macrocephaly\u2013capillary malformations","volume":"145","author":"Wright","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.cco.0000198021.99347.b9","article-title":"Oncogenic PI3K and its role in cancer","volume":"18","author":"Samuels","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib62","first-page":"222","article-title":"Hypoketotic hypofattyacidaemic hypoinsulinaemic hypoglycaemia in a child with hemihypertrophy? a new syndrome","volume":"61","author":"Hussain","year":"2004","journal-title":"Horm Res"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib63","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.1210878","article-title":"An activating variant of AKT2 and human hypoglycemia","volume":"334","author":"Hussain","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2013-3228","article-title":"Activating AKT2 variant: hypoinsulinemic hypoketotic hypoglycemia","volume":"99","author":"Arya","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib65","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00431-013-2053-0","article-title":"Biochemical studies in patients with hyperinsulinaemic hypoglycaemia","volume":"172","author":"Al-Otaibi","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib66","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1073\/pnas.0901933106","article-title":"Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling","volume":"106","author":"Gonzalez","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib67","doi-asserted-by":"crossref","first-page":"11285","DOI":"10.1073\/pnas.1934283100","article-title":"Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation","volume":"100","author":"Matsuzaki","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib68","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2106\/00004623-196749070-00001","article-title":"Macrodactyly","volume":"49","author":"Barsky","year":"1967","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1753193412451232","article-title":"Macrodactyly: options and outcomes","volume":"38","author":"Hardwicke","year":"2013","journal-title":"J Hand Surg Eur Vol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib70","doi-asserted-by":"crossref","first-page":"e0123092","DOI":"10.1371\/journal.pone.0123092","article-title":"Molecular and functional characterization of three different postzygotic mutations in PIK3CA-related overgrowth spectrum (PROS) patients: effects on PI3K\/AKT\/mTOR signaling and sensitivity to PIK3 inhibitors","volume":"10","author":"Loconte","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib71","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ng.2332","article-title":"Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA","volume":"44","author":"Lindhurst","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrg2626","article-title":"Sequencing technologies: the next generation","volume":"11","author":"Metzker","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib73","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/jlts.2001.24645","article-title":"mTOR inhibitors: an overview","volume":"7","author":"Neuhaus","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4615-1809-9_5","article-title":"Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells","volume":"1","author":"Wiederrecht","year":"1995","journal-title":"Prog Cell Cycle Res"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1758834014530023","article-title":"The PI3K\/AKT\/mTOR pathway in breast cancer: targets, trials and biomarkers","volume":"6","author":"Paplomata","year":"2014","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib76","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib77","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1158\/0008-5472.CAN-09-0299","article-title":"Biochemical, cellular, and in\u00a0vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin","volume":"69","author":"Yu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib78","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1200\/JCO.2011.35.5263","article-title":"First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors","volume":"29","author":"Yap","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib79","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","article-title":"Development of PI3K inhibitors: lessons learned from early clinical trials","volume":"10","author":"Rodon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3577","article-title":"A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors","volume":"15","author":"Hudis","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib81","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/cncr.29363","article-title":"Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: a SWOG cooperative group trial (S1005)","volume":"121","author":"Ramanathan","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib82","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1158\/1535-7163.MCT-13-1043","article-title":"Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma","volume":"13","author":"Zhai","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S89967","article-title":"PI3K inhibitors as new cancer therapeutics: implications for clinical trial design","volume":"9","author":"Massacesi","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jmoldx.2017.04.001_bib84","doi-asserted-by":"crossref","first-page":"17162","DOI":"10.1038\/srep17162","article-title":"Repression of AKT signaling by ARQ 092 in cells and tissues from patients with Proteus syndrome","volume":"5","author":"Lindhurst","year":"2015","journal-title":"Sci Rep"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781730209X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781730209X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T07:49:35Z","timestamp":1576223375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152515781730209X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S152515781730209X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2017.04.001","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase\/AKT\/Mammalian Target of Rapamycin Pathway","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2017.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}